It certainly would be a good price (though above my average buy in price into BIN) - and yes, at current it appears we missed it. Anyway still have a small order waiting ... just in case;
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025